Skip to main content

Table 2 Elixhauser comorbidity profiles

From: Epidemiology of total hip arthroplasty: demographics, comorbidities and outcomes

THA

rTHA

 

Discharges (n = 2,838,742)

 

Discharges (n = 400,974)

Hypertension

1,716,272 (60.46%)

Hypertension

239,561 (59.74%)

Obesity

428,814 (15.11%)

Deficiency Anemias

70,229 (17.51%)

Chronic Pulmonary Disease

407,858 (14.37%)

Chronic Pulmonary Disease

67,859 (16.92%)

Hypothyroidism

388,394 (13.68%)

Fluid and Electrolyte Disorders

63,133 (15.74%)

Diabetes (Uncomplicated)

388,170 (13.67%)

Hypothyroidism

59,399 (14.81%)

Deficiency Anemias

387,928 (13.67%)

Obesity

59,202 (14.76%)

Depression

318,317 (11.21%)

Depression

57,911 (14.44%)

Fluid and Electrolyte Disorder

261,545 (9.21%)

Uncomplicated Diabetes

54,259 (13.53%)

Renal Failure

119,673 (4.22%)

Other Neurological Disorders

28,123 (7.01%)

Valvular Heart Disease

113,545 (4.00%)

Renal Failure

27,955 (6.97%)

Rheumatoid Arthritis/Collagen Vascular Disease

108,372 (3.82%)

Rheumatoid Arthritis/Collagen Vascular Disease

27,602 (6.88%)

Other Neurological Disorders

105,927 (3.73%)

Congestive Heart Failure

24,152 (6.02%)

Congestive Heart Failure

80,299 (2.83%)

Valvular Disease

20,709 (5.17%)

Peripheral Vascular Disorders

68,802 (2.42%)

Coagulopathy

16,292 (4.06%)

Coagulopathy

64,920 (2.29%)

Peripheral Vascular Disorders

13,677 (3.41%)

Psychoses

53,880 (1.90%)

Psychoses

12,344 (3.08%)

Chronic Blood Loss Anemias

50,668 (1.79%)

Weight Loss

12,123 (3.02%)

Alcohol Abuse

48,069 (1.69%)

Alcohol Abuse

9,816 (2.45%)

Diabetes (Complicated)

36,013 (1.27%)

Chronic Blood Loss Anemias

9,295 (2.32%)

Liver Disease

30,597 (1.08%)

Liver Disease

8,051 (2.01%)

Pulmonary Circulation Disorders

24,838 (0.88%)

Complicated Diabetes

6,718 (1.68%)

Drug Abuse

20,699 (0.73%)

Pulmonary Circulation Disorders

6,716 (1.68%)

Weight Loss

16,756 (0.59%)

Drug Abuse

5,708 (1.42%)

Solid Tumor without Metastasis

16,463 (0.58%)

Paralysis

3,848 (0.96%)

Lymphoma

10,662 (0.38%)

Solid Tumor without Metastasis

3,028 (0.76%)

Paralysis

10,199 (0.36%)

Lymphoma

2,261 (0.56%)

Metastatic Cancer

8,225 (0.29%)

Metastatic Cancer

2,240 (0.56%)

Acquired Immune Deficiency Syndrome (AIDS)

3,644 (0.13%)

Acquired Immune Deficiency Syndrome (AIDS)

640 (0.16%)

Peptic Ulcer Disease Excluding Bleeding

494 (0.02%)

Peptic Ulcer Disease Excluding Bleeding

96 (0.02%)

  1. Elixhauser comorbidity profile collected from the NIS database of patients undergoing THA and rTHA from 2006 to the third quarter of 2015